Meet Feather, the startup building the ‘Android of robotics’ for developers
Feather is betting on a customizable, $30,000 platform built for software developers.
Startups
Databricks buys Row Zero and is scouting for more startups to acquire
Databricks has brought cloud spreadsheet startup Row Zero, adding yet another acquisition to its 2026 shopping spree.
TechCrunch Founder Summit 2026: Everything you need to know
TechCrunch Founder Summit is a full-day gathering in Boston on November 4 where founders across all stages connect with top VCs and experienced entrepreneurs to gain tactical insights on building and scaling their companies.
Meet the next wave of VCs judging Startup Battlefield 200 at TechCrunch Disrupt 2026
Meet the next wave of VCs judging the Startup Battlefield 200 contenders on the main stage at TechCrunch Disrupt 2026. Register by September 25 at 11:59 p.m. PT, to save up to $200 and to get a front-row seat to one of the most intense startup pitch competitions.
Shield AI, Waabi, and General Motors on building AI when failure is not an option at TechCrunch Disrupt 2026
Leaders from Waabi, Shield AI, and General Motors join the Real World AI Stage at TechCrunch Disrupt 2026 to talk building AI. Save up to $200 by September 25 at 11:59 p.m. PT. Get a second pass at 50% off.
Ando wants to take on Slack with a team messaging app that lets humans and agents work together
Ando has raised $20 million in pre-seed and seed funding from investors including Accel, Index Ventures, and Emergence.
TechCrunch Disrupt 2026: Cal AI’s Zach Yadegari on how to create viral growth and capitalize on it
Zach Yadegari joins the Builders Stage at TechCrunch Disrupt 2026 to share how he capitalized on viral growth. Save up to $200 before September 25. Save 50% on a second pass.
2 days left to save up to $200 on a TechCrunch Disrupt 2026 pass — reason 4 of 5 to attend
Reason 4 of 5 to attend TechCrunch Disrupt 2026: Practical answers. Two days left to save up to $200 on your pass. Savings disappear after September 25 at 11:59 p.m. PT. Bring a second guest at 50% off.
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Modal Motors is trying to cut China out of electric motors entirely
The startup is working on small, light motors with no rare-earth magnets that are suited for drones, fans, and robots.